Tranexamic Acid Tablet, Film Coated
Product Images NDC 63629-8838

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 63629-8838). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636298838)

Label (Lbl636298838)
This is a product description of Tranexamic Acid Tablet, USP by BRP Pharmaceuticals, intended for prescription only. The tablets contain Tranexamic Acid, each containing 650 mg. The recommended dosage is taking two 650 mg tablets, three times per day during menstruation, with a maximum of 6 tablets per day. Each package has 30 tablets with NDC 63629-8838-1. Store in a controlled room temperature, in a tightly closed and light-resistant container.*
FDA Label Image

Structural Formula For Tranexamic Acid (Tranexamic Acid Tablets A202093 1)

FDA Label Image

Figure 1 (The efficacy of Tranexamic acid tablets 3900 mg/day over 3 menstrual cycles and over 6 menstrual cycles was demonstrated versus placebo in the double-blind, placebo-controlled efficacy studies.)

Figure 1 (The efficacy of Tranexamic acid tablets 3900 mg/day over 3 menstrual cycles and over 6 menstrual cycles was demonstrated versus placebo in the double-blind, placebo-controlled efficacy studies.)
This text appears to be a table displaying the Mean Menstrual Blood Loss (in mL) for different treatments and cycles. The treatments listed are Tranexamic Acd Talls 3300 mgiay cycestudy, Placebo el study, Tranexamic Ack Tabiets 3900 mojdsy el study, and Placebo Gycl study. The cycles listed are Baseline, First Cycle, Second Cycle, Third Cycle, Fourth Cycle, Fifth Cycle, and Sixth Cycle. The table is likely part of a scientific or medical study evaluating the effectiveness of different treatments for menstrual bleeding.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.